Pegcetacoplan maintains early improvements in post-transplant recurrent C3G and IC-MPGN: 1-year results from the phase 2 NOBLE trial (Banff-PITOR 2024 C3G) - Apellis Medical Hub

Home / Congress Presentations / IC-MPGN and C3G / Banff-PITOR 2024

Pegcetacoplan maintains early improvements in post-transplant recurrent C3G and IC-MPGN: 1-year results from the phase 2 NOBLE trial

Share Via Email

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.